copaydosingefficacyresourcesafety

THIS SITE IS INTENDED FOR US AUDIENCES ONLY

‹

Unsubscribe

You may unsubscribe from Otezla® (apremilast) e-mail communications from your Celgene sales representative

Indications & Important Safety Information

Please click here for Full Prescribing Information.

You are leaving the Otezla® (apremilast) website

Do you wish to leave this site?

Are You a
Healthcare Professional?

The FDA approves a new indication for Otezla® (apremilast) Learn more about this treatment option for your patients
EXPLORE